Shotgun proteomics of archival triple-negative breast cancer samples (Q38398043)

2 September 2017

Shotgun proteomics of archival triple-negative breast cancer samples (English)

1 reference

triple-negative breast cancer

2 September 2017

1 reference

Angelo Gámez-Pozo

1

1 reference

2 September 2017

Nuria Ibarz Ferrer

2

1 reference

2 September 2017

Eva Ciruelos

3

1 reference

2 September 2017

Rocío López-Vacas

4

1 reference

2 September 2017

Fernando García Martínez

5

1 reference

2 September 2017

Enrique Espinosa

6

1 reference

2 September 2017

Juan Ángel Fresno Vara

7

1 reference

2 September 2017

6 March 2013

1 reference

Proteomics - Clinical Applications

2 September 2017

1 reference

2 September 2017

7

1 reference

2 September 2017

3-4

1 reference

2 September 2017

283-291

1 reference

European cancer mortality predictions for the year 2011.

2 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

The present and future of gene profiling in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

Precision proteomics: the case for high resolution and high mass accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

Evolution of clinical proteomics and its role in medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

Comparison of gene expression profiling by reverse transcription quantitative PCR between fresh frozen and formalin-fixed, paraffin-embedded breast cancer tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

Protein phosphorylation analysis in archival clinical cancer samples by shotgun and targeted proteomics approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

Proteome analysis of microdissected formalin-fixed and paraffin-embedded tissue specimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

Proteomic analysis of formalin-fixed prostate cancer tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

Efficient method for the proteomic analysis of fixed and embedded tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

Protein extraction from formalin-fixed, paraffin-embedded tissue sections: quality evaluation by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

Equivalence of protein inventories obtained from formalin-fixed paraffin-embedded and frozen tissue in multidimensional liquid chromatography-tandem mass spectrometry shotgun proteomic analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

Extraction and analysis of diagnostically useful proteins from formalin-fixed, paraffin-embedded tissue sections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

DNA extraction from archival formalin-fixed, paraffin-embedded tissue sections based on the antigen retrieval principle: heating under the influence of pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

Setting proteins free: progresses and achievements in proteomics of formalin-fixed, paraffin-embedded tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

Label-free protein profiling of formalin-fixed paraffin-embedded (FFPE) heart tissue reveals immediate mitochondrial impairment after ionising radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

Utility of formalin-fixed, paraffin-embedded liver biopsy specimens for global proteomic analysis in nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

PTRF/cavin-1 and MIF proteins are identified as non-small cell lung cancer biomarkers by label-free proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

PANTHER: a library of protein families and subfamilies indexed by function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

Transcription, genomes, function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

A refined molecular taxonomy of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

An iron regulatory gene signature predicts outcome in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

Adjusting batch effects in microarray expression data using empirical Bayes methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

The use of an antibody drug conjugate, glembatumumab vedotin (CDX-011), for the treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

Pressure-assisted protein extraction: a novel method for recovering proteins from archival tissue for proteomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

Targeting triple-negative breast cancer: optimising therapeutic outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

On the Origin of Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

EGFR expression correlates with decreased disease-free survival in triple-negative breast cancer: a retrospective analysis based on a tissue microarray.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

Rare oncogenic mutations of predictive markers for targeted therapy in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

CD151 accelerates breast cancer by regulating alpha 6 integrin function, signaling, and molecular organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

Development of efficient protein extraction methods for shotgun proteome analysis of formalin-fixed tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

Src: a potential target for the treatment of triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

PARP-1 expression in breast cancer including BRCA1-associated, triple negative and basal-like tumors: possible implications for PARP-1 inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

Ezrin phosphorylation on tyrosine 477 regulates invasion and metastasis of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

Tenascin C induces epithelial-mesenchymal transition-like change accompanied by SRC activation and focal adhesion kinase phosphorylation in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

PARP inhibitors stumble in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

Iniparib plus chemotherapy in metastatic triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

The two faces of Janus kinases and their respective STATs in mammary gland development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

Oral administration of penta-O-galloyl-β-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

Targeted therapy for triple-negative breast cancer: where are we?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

The Triple-Negative Subtype: New Ideas for the Poorest Prognosis Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200048

21 January 2018

Identifiers

DOI

10.1002/PRCA.201200048

1 reference

2 September 2017

1 reference